High-resolution view of HIV-1 reverse transcriptase initiation complexes and inhibition by NNRTI drugs
Initiation of HIV-1 reverse transcription occurs at the host tRNALys 3, which forms a complex with the 5’ end of the HIV-1 viral RNA and reverse transcriptase (RT). Here, the authors present the 2.8 Å cryo-EM structure of a minimal HIV-1 RT–vRNA–tRNALys 3 initiation complex (miniRTIC), and miniRTIC...
Guardado en:
Autores principales: | Betty Ha, Kevin P. Larsen, Jingji Zhang, Ziao Fu, Elizabeth Montabana, Lynnette N. Jackson, Dong-Hua Chen, Elisabetta Viani Puglisi |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/428ee5420f604c7da4a4e2a37fe10591 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
The Reverse Transcriptases Associated with CRISPR-Cas Systems
por: Nicolás Toro, et al.
Publicado: (2017) -
Associations between plasma nucleoside reverse transcriptase inhibitors concentrations and cognitive function in people with HIV.
por: Davide De Francesco, et al.
Publicado: (2021) -
Estimating the fitness cost of escape from HLA presentation in HIV-1 protease and reverse transcriptase.
por: Rafal Mostowy, et al.
Publicado: (2012) -
Reduced efficacy of HIV-1 integrase inhibitors in patients with drug resistance mutations in reverse transcriptase
por: Mark J. Siedner, et al.
Publicado: (2020) -
Prediction of mutational tolerance in HIV-1 protease and reverse transcriptase using flexible backbone protein design.
por: Elisabeth Humphris-Narayanan, et al.
Publicado: (2012)